Study links attempted suicide with genetic evidence identified in previous suicide research
...ple who might be at risk of suicide and offer drug companies a target for possible therapies. The data used by Willour and her team -- DNA samples, medical histories and psychiatric evaluations -- came from an independent study, CHIP, conducted at the University of Chicago, Johns Hopkins, and the National In...Tobacco companies obstructed science, history professor says
...c eye and within the scientific community. Tobacco companies funded skeptics, started health reassurance campai...true, this lack of proof would absolve the tobacco companies of any blame for deaths caused by smoking and any charges of fraud for their campaign against the li...Absence of health insurance coverage costs $1.47B in Maryland
... expenditures for the uninsured. Private insurance companies paid $95 million for the uninsured through hospital rates under Maryland's all-payer system, an amount reflected in higher insurance premiums for privately insured individuals. In addition, private physicians contributed an estimated $211 million in ...Physicists set 'speed limit' for future superconducting magnet
...ersities, national laboratories and pharmaceutical companies use even more powerful MR technology to study DNA, proteins and other complex molecules. About a dozen labs around the country take advantage of the highest magnetic field now in use -- 21.1 Tesla, which produces a magnetic field 10 times larger than...Feb. 16 event explores pills, politics and the public trust
...ng bags, with polls showing declining trust in the companies that make our medicines, and the media full of negative stories and depictions. From Vioxx lawsuits to the battle over Medicare prescription drug prices, drug manufacturers often find themselves on the defensive, adding to an existing public percept...New forecasting tool could reduce drug development costs
... to develop a new drug. But what if pharmaceutical companies had a way to predict which experimental drugs will ultimately get FDA approval, giving them the confidence to invest money in them, and which drugs will ultimately fail, allowing them to cut their losses early? In the February issue of Nature Revie...U-M, Harvard team propose way to make the most of health dollars
... today in the journal Health Affairs. Instead, companies should tailor their plans so that people who can g...t will actually pay the least for it. By doing so, companies might not only get more for their money, they might even save money in the long run by helping their...Embargoed Jan./Feb. Annals of Family Medicine tip sheet
...re is nothing inherently wrong with pharmaceutical companies communicating directly with consumers, they should adhere to the standards and ethics of medicine, not the standards and ethics of selling consumer products that present minimal risk and that physicians need to use caution before writing a prescripti...National research network launched to seek better treatments for brain injury, stroke and seizures
...y "spoke" hospitals and emergency medical response companies around the country. This week's kickoff is something that Bill Barsan, M.D., has been working toward for more than three years. He's the chair of the U-M's Department of Emergency Medicine, and principal investigator of the NETT clinical coordinat...Flu experts call for mandatory shots for health care workers
...s widely because there are very few pharmaceutical companies interested in manufacturing it. A bigger and more stable market for vaccine would lure more companies into the field, improving the capacity to quickly develop a pandemic vaccine. IDSA applauds the fede...Travelers need to know more about diarrhea
...sfaction of their clientele. "For example, tour companies with Web-based ticket sale systems could provide online brochures to customers at point-of-purchase, or links to further health information. Health regions provide excellent information to those who seek it out, but many travellers may not be aware t...Bayer and Onyx announce pivotal Nexavar kidney cancer study published in NEJM
... and statistical significance of the PFS data, the companies unblinded the trial and announced that patients who were receiving placebo were allowed to "cross over" to drug treatment. The first OS analysis conducted immediately before cross-over found a 39% improvement in OS for Nexavar patients (hazard ratio ...Benefits of testosterone treatment unknown, research shows
... evidence supporting testosterone's efficacy, drug companies have successfully driven its sale, Dr. Montori says. Currently, physicians may be prescribing testosterone to otherwise healthy men who report poor quality of life, limited sex drive and fatigue and may have somewhat low testosterone levels. These ...Better review of new technology is needed to reduce health costs
... industry--from medical institutions and insurance companies to Medicare and other administrative agencies--agree on the need for a new review system, she says. "Using study data that shows which patients will have a net benefit from a drug or procedure is called evidence-based technology assessment. Its im...Youth are receiving shorter inpatient stays for mental health treatment
...fore because of the pressure from health insurance companies to discharge patients quickly. In spite of this pressure, we have to consistently try to do what is best for the child and adolescent and their families," says Jeffrey Hunt, MD, director of Bradley's Adolescent Program. Over the years, Hunt's team...Australians support mandatory fitness testing to combat childhood obesity
...s for emerging Australian health and biotechnology companies to conduct and commercialise their research here....Effect of tobacco ads may backfire
...this the minute we saw the kind of ads the tobacco companies were creating," said Brian Flay, a professor in the Department of Public Health at Oregon State University. "Their objective is to get customers, not to stop customers from finding them." The study appears in the December issue of American Journal of...UW-Madison researchers clear way to stronger glass
...yeglasses, this new glass may allow pharmaceutical companies the opportunity to explore previously unusable drug compounds. When considered at the molecular level, most solid materials can be described as either crystals or glasses, explains lead author Mark Ediger, a UW-Madison chemistry professor. The diff...PhD researcher develops inexpensive, sustainable production method in just 2 years
...ely, we must however consider the investments that companies have already made in existing production plants. Many companies will therefore only use this new method if a new factory is built." The combination of ionic liquids...Rockhampton part of worldwide fight against respiratory infections
...d the USA and is working with major pharmaceutical companies on the research and development of patents to the clinical trials stage for a range of new therapies. "We currently treat respiratory infections with antibiotics but we need to find better preventative therapies otherwise well continue increase the...